These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


40 related items for PubMed ID: 13446203

  • 1. [Potentiation of the convulsant effects of strychnine by CT 3318 bis-(2, 3-dihydro-2-piperidinomethyl-5-benzofuranyl) ketone dimethiodide].
    ZANDA CE.
    Boll Soc Ital Biol Sper; 1957; 33(1-2):80-1. PubMed ID: 13446203
    [No Abstract] [Full Text] [Related]

  • 2. [Characterization of the curarizing activity of CT 3318 bis-(2, 3-dihydro-2-piperidino-methyl-5-benzofuranyl) ketone dimethiodide].
    VARGIU L, ZANDA CE.
    Boll Soc Ital Biol Sper; 1957; 33(1-2):81-4. PubMed ID: 13446204
    [No Abstract] [Full Text] [Related]

  • 3. [Significance of cholinesterase inhibition by in vitro manifestation of various effects of a specific inhibitor, bis(2,3-dihydro-2-piperidinomethy1-5-benzofuranyl) ketone dimethiodide (CT-3318)].
    ZANDA CE.
    Arch Int Pharmacodyn Ther; 1959 May 01; 120(1):53-63. PubMed ID: 13662037
    [No Abstract] [Full Text] [Related]

  • 4. [Specific anticholinesterase properties of bis (2, 3-dihydro-2-piperidinomethyl-5-benzofuranyl) ketone dimethiodide (3318 CT). II. Pharmacological properties].
    JACOB J.
    Arch Int Pharmacodyn Ther; 1956 Jun 01; 106(4):395-436. PubMed ID: 13341135
    [No Abstract] [Full Text] [Related]

  • 5. [Specific anticholinesterase properties of bis(2,3-dihydro-2-piperidinomethyl-5-benzoturanyl) ketone dimethiodide (3318 CT). 1. Relation between chemical structure and anticholinesterase activity; inhibitory power in vitro and in vivo].
    JACOB J.
    Arch Int Pharmacodyn Ther; 1955 May 01; 101(4):446-68. PubMed ID: 13239238
    [No Abstract] [Full Text] [Related]

  • 6. Effect of bis(acetato)tetrakis(imidazole) copper(II) in delaying the onset and reducing the mortality rate of strychnine- and thiosemicarbazide- induced convulsions.
    Abdul-Ghani AS, Abu-Hijleh AL, Qazzaz M.
    Biol Trace Elem Res; 2004 Oct 01; 101(1):87-95. PubMed ID: 15516705
    [Abstract] [Full Text] [Related]

  • 7. [Role of central mediators in experimental production and drug therapy of some extrapyramidal disorders].
    ANTONOV L.
    Suvr Med (Sofiia); 1961 Oct 01; 12(12)():19-29. PubMed ID: 14013386
    [No Abstract] [Full Text] [Related]

  • 8. [CHANGES IN THE ELECTRICAL ACTIVITY AND EXCITABILITY OF THE CORTEX UNDER THE INFLUENCE OF DIMEZOLE AND STRYCHNINE].
    BLAGODATOVA ET.
    Fiziol Zh SSSR Im I M Sechenova; 1963 Apr 01; 49():412-8. PubMed ID: 14066321
    [No Abstract] [Full Text] [Related]

  • 9. Tremorigenic and convulsant actions of intracerebrally administered vegetative poisons in the mouse.
    Molnár J, György L, Pfeifer KA, Nádor K.
    Acta Physiol Acad Sci Hung; 1967 Apr 01; 31(3):249-56. PubMed ID: 4382164
    [No Abstract] [Full Text] [Related]

  • 10. [Potentiation of drug effects by cholinergic drugs].
    CHEMNITIUS KH.
    Acta Biol Med Ger; 1958 Apr 01; 1(2):117-29. PubMed ID: 13594093
    [No Abstract] [Full Text] [Related]

  • 11. [Differentiation of the cholinesterase activity of biological matter of various origins. II. Inhibitory effect of bis(piperidinomethyl cumaranil 5) ketone diiodomethylate (CT 3318)].
    PAULESU F, VARGIU L.
    Arch Int Pharmacodyn Ther; 1955 Nov 01; 104(1):11-8. PubMed ID: 13283638
    [No Abstract] [Full Text] [Related]

  • 12. The effects of convulsant and anticonvulsant treatments on the behavioural effects of ultrasound presentation in Lister hooded rats.
    Commissaris RL, Beckett SR, Marsden CA.
    Behav Pharmacol; 1998 Mar 01; 9(2):113-26. PubMed ID: 10065931
    [Abstract] [Full Text] [Related]

  • 13. Reduction of gamma-aminobutyric acid (GABA)-mediated transmission by a convulsant benzodiazepine.
    Schlosser W, Franco S.
    J Pharmacol Exp Ther; 1979 Nov 01; 211(2):290-5. PubMed ID: 501563
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and convulsant effects of 2- and 3-substituted strychnine derivatives.
    Bohlin L, Ali Y, Iskander GM.
    Acta Pharm Suec; 1975 Nov 01; 12(5-6):461-6. PubMed ID: 1217499
    [No Abstract] [Full Text] [Related]

  • 15. Antagonism between a bis-quaternary oxamide, Win 8078, and depolarizing and competitive blocking agents.
    KARCZMAR AG.
    J Pharmacol Exp Ther; 1957 Jan 01; 119(1):39-47. PubMed ID: 13417058
    [No Abstract] [Full Text] [Related]

  • 16. [Independence of the effects of a selective acetylcholinesterase inhibitor (CT 3318) on striated muscle from its antienzymatic activity].
    GESSA GL, SANGIORGI G.
    Boll Soc Ital Biol Sper; 1959 May 15; 35(9):506-9. PubMed ID: 13662448
    [No Abstract] [Full Text] [Related]

  • 17. [Enhancement of the convulsant action of strychnine following administration of kynurenines into the cerebral ventricles of frogs].
    Ryzhov IV.
    Biull Eksp Biol Med; 1980 May 15; 89(5):572-4. PubMed ID: 6967332
    [Abstract] [Full Text] [Related]

  • 18. Effects of convulsant ligands of the GABA-benzodiazepine receptor complex in conflict and learning tasks in mice.
    Venault P, Chapouthier G, Prado de Carvalho L, Rossier J.
    Encephale; 1992 May 15; 18(6):655-60. PubMed ID: 1342664
    [Abstract] [Full Text] [Related]

  • 19. [Significance of cholinesterase; pharmacological activity of a specific inhibitor of true cholinesterase: CT-3318].
    ZANDA CE.
    Boll Soc Ital Biol Sper; 1956 Dec 15; 32(12):1445-7. PubMed ID: 13446082
    [No Abstract] [Full Text] [Related]

  • 20. Proceedings: The effect of dopamine on strychnine-induced convulsions in young chicks.
    Osuide G, Wambebe C.
    West Afr J Pharmacol Drug Res; 1975 Jun 15; 2(1):73P-74P. PubMed ID: 1226744
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 2.